Jamie L Adams1,2, Karthik Dinesh3, Mulin Xiong2, Christopher G Tarolli1,2, Saloni Sharma2, Nirav Sheth4, A J Aranyosi4, William Zhu2, Steven Goldenthal2, Kevin M Biglan1,2, E Ray Dorsey1,2, Gaurav Sharma3,5. 1. Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA. 2. Center for Health and Technology, University of Rochester Medical Center, Rochester, New York, USA. 3. Department of Electrical and Computer Engineering, University of Rochester Medical Center, Rochester, New York, USA. 4. MC10 Inc., Lexington, Massachusetts, USA. 5. Department of Computer Science, University of Rochester, Rochester, New York, USA.
Abstract
BACKGROUND: Clinician rating scales and patient-reported outcomes are the principal means of assessing motor symptoms in Parkinson disease and Huntington disease. However, these assessments are subjective and generally limited to episodic in-person visits. Wearable sensors can objectively and continuously measure motor features and could be valuable in clinical research and care. METHODS: We recruited participants with Parkinson disease, Huntington disease, and prodromal Huntington disease (individuals who carry the genetic marker but do not yet exhibit symptoms of the disease), and controls to wear 5 accelerometer-based sensors on their chest and limbs for standardized in-clinic assessments and for 2 days at home. The study's aims were to assess the feasibility of use of wearable sensors, to determine the activity (lying, sitting, standing, walking) of participants, and to survey participants on their experience. RESULTS: Fifty-six individuals (16 with Parkinson disease, 15 with Huntington disease, 5 with prodromal Huntington disease, and 20 controls) were enrolled in the study. Data were successfully obtained from 99.3% (278/280) of sensors dispatched. On average, individuals with Huntington disease spent over 50% of the total time lying down, substantially more than individuals with prodromal Huntington disease (33%, p = 0.003), Parkinson disease (38%, p = 0.01), and controls (34%; p < 0.001). Most (86%) participants were "willing" or "very willing" to wear the sensors again. CONCLUSIONS: Among individuals with movement disorders, the use of wearable sensors in clinic and at home was feasible and well-received. These sensors can identify statistically significant differences in activity profiles between individuals with movement disorders and those without. In addition, continuous, objective monitoring can reveal disease characteristics not observed in clinic.
BACKGROUND: Clinician rating scales and patient-reported outcomes are the principal means of assessing motor symptoms in Parkinson disease and Huntington disease. However, these assessments are subjective and generally limited to episodic in-person visits. Wearable sensors can objectively and continuously measure motor features and could be valuable in clinical research and care. METHODS: We recruited participants with Parkinson disease, Huntington disease, and prodromal Huntington disease (individuals who carry the genetic marker but do not yet exhibit symptoms of the disease), and controls to wear 5 accelerometer-based sensors on their chest and limbs for standardized in-clinic assessments and for 2 days at home. The study's aims were to assess the feasibility of use of wearable sensors, to determine the activity (lying, sitting, standing, walking) of participants, and to survey participants on their experience. RESULTS: Fifty-six individuals (16 with Parkinson disease, 15 with Huntington disease, 5 with prodromal Huntington disease, and 20 controls) were enrolled in the study. Data were successfully obtained from 99.3% (278/280) of sensors dispatched. On average, individuals with Huntington disease spent over 50% of the total time lying down, substantially more than individuals with prodromal Huntington disease (33%, p = 0.003), Parkinson disease (38%, p = 0.01), and controls (34%; p < 0.001). Most (86%) participants were "willing" or "very willing" to wear the sensors again. CONCLUSIONS: Among individuals with movement disorders, the use of wearable sensors in clinic and at home was feasible and well-received. These sensors can identify statistically significant differences in activity profiles between individuals with movement disorders and those without. In addition, continuous, objective monitoring can reveal disease characteristics not observed in clinic.
Authors: Ryan P Duncan; Stephanie A Combs-Miller; Marie E McNeely; Abigail L Leddy; James T Cavanaugh; Leland E Dibble; Terry D Ellis; Matthew P Ford; K Bo Foreman; Gammon M Earhart Journal: Gait Posture Date: 2016-11-22 Impact factor: 2.840
Authors: Kelly L Andrzejewski; Ariel V Dowling; David Stamler; Timothy J Felong; Denzil A Harris; Cynthia Wong; Hang Cai; Ralf Reilmann; Max A Little; Joseph T Gwin; Kevin M Biglan; E Ray Dorsey Journal: J Huntingtons Dis Date: 2016-06-18
Authors: M L Dontje; M H G de Greef; A D Speelman; M van Nimwegen; W P Krijnen; R P Stolk; Y P T Kamsma; B R Bloem; M Munneke; C P van der Schans Journal: Parkinsonism Relat Disord Date: 2013-06-12 Impact factor: 4.891
Authors: Marlies van Nimwegen; Arlène D Speelman; Esther J M Hofman-van Rossum; Sebastiaan Overeem; Dorly J H Deeg; George F Borm; Marleen H L van der Horst; Bastiaan R Bloem; Marten Munneke Journal: J Neurol Date: 2011-05-26 Impact factor: 4.849
Authors: Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak Journal: J Neurol Date: 2020-01-11 Impact factor: 4.849
Authors: He Zhou; Hung Nguyen; Ana Enriquez; Louie Morsy; Michael Curtis; Timothy Piser; Christopher Kenney; Christopher D Stephen; Anoopum S Gupta; Jeremy D Schmahmann; Ashkan Vaziri Journal: Neurol Sci Date: 2021-10-19 Impact factor: 3.307
Authors: Sarah J Tabrizi; Carlos Estevez-Fraga; Willeke M C van Roon-Mom; Michael D Flower; Rachael I Scahill; Edward J Wild; Ignacio Muñoz-Sanjuan; Cristina Sampaio; Anne E Rosser; Blair R Leavitt Journal: Lancet Neurol Date: 2022-07 Impact factor: 59.935
Authors: Florian Lipsmeier; Cedric Simillion; Atieh Bamdadian; Rosanna Tortelli; Lauren M Byrne; Yan-Ping Zhang; Detlef Wolf; Anne V Smith; Christian Czech; Christian Gossens; Patrick Weydt; Scott A Schobel; Filipe B Rodrigues; Edward J Wild; Michael Lindemann Journal: J Med Internet Res Date: 2022-06-28 Impact factor: 7.076
Authors: Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak Journal: J Neuroeng Rehabil Date: 2020-12-01 Impact factor: 4.262
Authors: Vrutangkumar V Shah; James McNames; Graham Harker; Martina Mancini; Patricia Carlson-Kuhta; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak Journal: Sensors (Basel) Date: 2020-10-12 Impact factor: 3.576